The Most Common Side Effects
Gastrointestinal issues are by far the most frequently reported side effects of semaglutide. Nausea affects roughly 40-45% of patients, particularly during the first few weeks and after dose increases. Other common GI side effects include diarrhea (about 30%), vomiting (around 25%), and constipation (about 24%). These numbers can sound alarming, but context matters: most side effects are mild to moderate, and they tend to improve significantly over time as your body adjusts.
When Side Effects Typically Start
Most patients notice side effects within the first week of starting semaglutide or after a dose increase. The first two to four weeks on a new dose are usually when symptoms are most noticeable. By weeks four to six at a stable dose, the majority of patients report a meaningful reduction in side effects. This is exactly why the medication uses a gradual titration schedule — starting at a low dose and increasing slowly gives your body time to adapt.
How to Manage Nausea
Nausea is the number one complaint, but there are effective strategies to manage it. Eat smaller, more frequent meals instead of large portions. Avoid greasy, fried, or heavily spiced foods, especially in the first few weeks. Stay well hydrated throughout the day — dehydration makes nausea worse. Eating bland, protein-rich foods tends to be better tolerated. Some patients find that ginger tea, peppermint, or eating crackers before meals helps. If nausea is severe, your provider may recommend a slower dose titration or temporary use of anti-nausea medication.
Serious Side Effects to Watch For
While rare, some side effects require immediate medical attention. These include severe abdominal pain that doesn't go away (which could indicate pancreatitis), signs of gallbladder problems (intense pain in the upper right abdomen), allergic reactions (swelling of face, lips, or tongue), and changes in vision. Semaglutide also carries a boxed warning about thyroid C-cell tumors observed in animal studies, though this has not been confirmed in humans. Patients with a personal or family history of medullary thyroid carcinoma should not use semaglutide.
The Role of Your Provider
Having a qualified medical provider monitor your treatment is essential, not optional. Your provider can adjust your dosing schedule, recommend strategies for managing side effects, and identify any concerning symptoms early. This is one of the most important factors when choosing a telehealth weight loss provider — make sure the platform includes ongoing medical oversight, not just an initial prescription. Regular check-ins, easy access to your care team, and responsive support can make the difference between a rough experience and a manageable one.
